+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Neurostimulation Devices Global Market Report 2020-30: COVID-19 Impact and Recovery

  • ID: 4871539
  • Report
  • October 2020
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Cochlear Ltd
  • DePuy Synthes Inc
  • MED-EL
  • NDI Medical
  • NeuroPace Inc
  • Nevro Corporation
Neurostimulation Devices Global Market Report 2020-30: COVID-19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global neurostimulation devices market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:

Where is the largest and fastest growing market for the neurostimulation devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Neurostimulation Devices Market Global Report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive land scape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive land scape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:
1) By Product: Implantable Devices; External Devices
2) By Application: Pain Management; Epilepsy; Essential Tremor; Urinary and Fecal Incontinence; Depression; Dystonia; Gastroparesis; Parkinson's Disease
3) By End User: Hospitals; Rehabilitation Centers; Medical Clinic
4) By Implantable Devices: Cochlear Implants; Deep Brain Stimulation; Spinal Cord Stimulation; Vagus Nerve Stimulation; Sacral Nerve Stimulation; Gastric Electric Stimulation 5) By External Devices: Transcranial Magnetic Stimulation (TMS); Transcutaneous Electrical Nerve Stimulation (TENS)

Companies Mentioned: Medtronic; Cyberonics; Boston Scientific Corporation; St. Jude Medical; Nevro Corporation

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cochlear Ltd
  • DePuy Synthes Inc
  • MED-EL
  • NDI Medical
  • NeuroPace Inc
  • Nevro Corporation

1. Executive Summary2. Neurostimulation Devices Market Characteristics
3. Neurostimulation Devices Market Size And Growth
3.1. Global Neurostimulation Devices Historic Market, 2015-2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Neurostimulation Devices Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Neurostimulation Devices Market Segmentation
4.1. Global Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Implantable Devices
  • External Devices
4.2. Global Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Pain Management
  • Epilepsy
  • Essential Tremor
  • Urinary and Fecal Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson's Disease
4.3. Global Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospitals
  • Rehabilitation Centers
  • Medical Clinic
4.4. Global Neurostimulation Devices Market, Segmentation By Implantable Devices, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Cochlear Implants
  • Deep Brain Stimulation
  • Spinal Cord Stimulation
  • Vagus Nerve Stimulation
  • Sacral Nerve Stimulation
  • Gastric Electric Stimulation
4.5. Global Neurostimulation Devices Market, Segmentation By External Devices, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Transcranial Magnetic Stimulation (TMS)
  • Transcutaneous Electrical Nerve Stimulation (TENS)

5. Neurostimulation Devices Market Regional And Country Analysis
5.1. Global Neurostimulation Devices Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Neurostimulation Devices Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6. Asia-Pacific Neurostimulation Devices Market
6.1. Asia-Pacific Neurostimulation Devices Market Overview
6.2. Asia-Pacific Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.4. Asia-Pacific Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
7. China Neurostimulation Devices Market
7.1. China Neurostimulation Devices Market Overview
7.2. China Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.4. China Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
8. India Neurostimulation Devices Market
8.1. India Neurostimulation Devices Market Overview
8.2. India Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.4. India Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9. Japan Neurostimulation Devices Market
9.1. Japan Neurostimulation Devices Market Overview
9.2. Japan Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.4. Japan Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10. Australia Neurostimulation Devices Market
10.1. Australia Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.3. Australia Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11. Indonesia Neurostimulation Devices Market
11.1. Indonesia Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.3. Indonesia Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12. South Korea Neurostimulation Devices Market
12.1. South Korea Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.3. South Korea Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13. Western Europe Neurostimulation Devices Market
13.1. Western Europe Neurostimulation Devices Market Overview
13.2. Western Europe Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.4. Western Europe Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14. UK Neurostimulation Devices Market
14.1. UK Neurostimulation Devices Market Overview
14.2. UK Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.4. UK Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15. Germany Neurostimulation Devices Market
15.1. Germany Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.3. Germany Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16. France Neurostimulation Devices Market
16.5. France Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.6. France Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.7. France Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17. Eastern Europe Neurostimulation Devices Market
17.1. Eastern Europe Neurostimulation Devices Market Overview
17.2. Eastern Europe Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.4. Eastern Europe Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18. Russia Neurostimulation Devices Market
18.1. Russia Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.3. Russia Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19. North America Neurostimulation Devices Market
19.1. North America Neurostimulation Devices Market Overview
19.2. North America Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.4. North America Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20. USA Neurostimulation Devices Market
20.1. USA Neurostimulation Devices Market Overview
20.2. USA Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.4. USA Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21. South America Neurostimulation Devices Market
21.1. South America Neurostimulation Devices Market Overview
21.2. South America Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.4. South America Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22. Brazil Neurostimulation Devices Market
22.1. Brazil Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.3. Brazil Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23. Middle East Neurostimulation Devices Market
23.1. Middle East Neurostimulation Devices Market Overview
23.2. Middle East Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.4. Middle East Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24. Africa Neurostimulation Devices Market
24.1. Africa Neurostimulation Devices Market Overview
24.2. Africa Neurostimulation Devices Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.4. Africa Neurostimulation Devices Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
25. Neurostimulation Devices Market Competitive Landscape And Company Profiles
25.1. Neurostimulation Devices Market Competitive Landscape
25.2. Neurostimulation Devices Market Company Profiles
25.2.1. Medtronic
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Cyberonics
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Boston Scientific Corporation
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. St. Jude Medical
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Nevro Corporation
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Neurostimulation Devices Market27. Neurostimulation Devices Market Trends And Strategies28. Neurostimulation Devices Market Future Outlook and Potential Analysis
29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cochlear Ltd
  • DePuy Synthes Inc
  • MED-EL
  • NDI Medical
  • NeuroPace Inc
  • Nevro Corporation
The neurostimulation devices market consists of sales of surgically or externally placed neurostimulators and related services. The neurostimulation devices are designed to deliver electrical stimulation to specific parts of the patient's brain, spinal cord or peripheral nervous system for the treatment of various conditions such as chronic pain, movement disorders, epilepsy and Parkinson's disease. The neurostimulation devices includes spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators and cortical stimulators.

The global neurostimulation devices market is expected to decline from $6.8 billion in 2019 to $5.8 billion in 2020 at a compound annual growth rate (CAGR) of -15.1%. The decline is mainly because of worldwide supply and demand mismatches of resources due to the COVID-19 outbreak. There is an inadequate production of devices used in neurological disease treatment, due to the restrictions imposed by governments of various countries to shutdown factories or function with minimal staffing in order to contain the spread of virus and keep the staff safe. Additionally, the restrictions on non-essential medical services also hampered the market growth. The market is then expected to recover and grow at a CAGR of 11.6% from 2021 and reach $10.5 billion in 2023.

Rising geriatric population across the globe is driving the growth of the nerostimulation device market. An increasing number of population is ageing and this geriatric population is falling prey to different neurobiological disorders. For instance, according to World Population Ageing Report, in 2017, there were an estimated 962 million people aged 60 or over globally, which is 13% of the total global population. According to the population reference bureau, the number of Americans ageing 65 and older is projected to more than double from 46 million in 2015 to over 98 million by 2060. According to the StastsCan, 2015, over 5.7 million Canadians have aged 65 and older, which was 16.1 % of Canadian population.

The high cost associated with the neurostimulation Devices will impede the growth of the market. For example, the average price of the neuromodulation devices for chronic pain management ranges from $13920 to $17940 and the average price of neuromodulation devices for epilepsy ranges from $25420 to $25970. Although the device construction between neurostimulation and cardiac rhythm management devices is similar, neuromodulation generators are 67 percent more expensive than ardiac rhythm management devices.

Minimally invasive treatments are being developed for the treatment of various neurological disorders. The neurostimulation devices are being innovated in a way to cause minimum invasion during the neurological treatments. For example, Deep Brain Stimulation (DBS) is a minimally invasive surgical procedure to treat neurological symptoms of Parkinson’s disease, including tremors, rigidity, and movement control. DBS uses a neurostimulation device, similar to a heart pacemaker, to deliver electrical pulses to a very precise location in the brain circuits that influence Parkinson’s disease symptoms. The electrical pulses from the DBS device blocks the activity of these circuits so the rest of the brain can function more normally.

USFDA strictly regulates the approval of medical devices depending on their class which is based on the risk associated with the device. There are relatively few class I neurological devices. Majority of the neurological devices are classified under Class II and Class III. Class II devices include neurostimulators, aneurysm clips, and blood clot retrievers. Examples of Class III devices are deep brain stimulators and medical devices for the treatment of brain tumors. Approval of class III medical devices is complicated and requires clinical trials. The time taken for the trials can be 36 months or more, depending on the extent of clinical trials and additional information that FDA might request. Also, European Union has recently taken steps to strengthen its regulatory approval process significantly, and this is expected to delay approvals in Europe. The delay in regulatory approvals and high cost of interventional devices are the major challenges faced by the companies involved in the manufacture of neurological devices.

In January 2018, LivaNova PLC, a market-leading medical technology company, acquired ImThera medical for USD 225 million. ImThera is a privately held company focused on neurostimulation for the treatment of obstructive sleep apnea (“OSA”). ImThera manufactures an implantable device that stimulates multiple tongue muscles via the hypoglossal nerve, which opens the airway while a patient is sleeping. This acquisition has enhanced the neuromodulation business of LivaNova PLC.

Major players in the market are Medtronic, Cyberonics, Boston Scientific Corporation, St. Jude Medical, Nevro Corporation
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Medtronic
  • Cyberonics
  • Boston Scientific Corporation
  • St. Jude Medical
  • Nevro Corporation
  • Neuronetics Inc
  • NeuroPace Inc
  • NeuroSigma Inc
  • Cochlear Ltd
  • NDI Medical
  • Synapse Biomedical Inc
  • MED-EL
  • LivaNova PLC
  • DePuy Synthes Inc
Note: Product cover images may vary from those shown

Loading
LOADING...